Cell surface expression of v-fms-coded glycoproteins is required for transformation.

AUTOR(ES)

Roussel, M F

RESUMO

The viral oncogene v-fms encodes a transforming glycoprotein with in vitro tyrosine-specific protein kinase activity. Although most v-fms-coded molecules remain internally sequestered in transformed cells, a minor population of molecules is transported to the cell surface. An engineered deletion mutant lacking 348 base pairs of the 3.0-kilobase-pair v-fms gene encoded a polypeptide that was 15 kilodaltons smaller than the wild-type v-fms gene product. The in-frame deletion of 116 amino acids was adjacent to the transmembrane anchor peptide located near the middle of the predicted protein sequence and 432 amino acids from the carboxyl terminus. The mutant polypeptide acquired N-linked oligosaccharide chains, was proteolytically processed in a manner similar to the wild-type glycoprotein, and exhibited an associated tyrosine-specific protein kinase activity in vitro. However, the N-linked oligosaccharides of the mutant glycoprotein were not processed to complex carbohydrate chains, and the glycoprotein was not detected at the cell surface. Cells expressing high levels of the mutant glycoprotein did not undergo morphological transformation and did not form colonies in semisolid medium. The transforming activity of the v-fms gene product therefore appears to be mediated through target molecules on the plasma membrane.

Documentos Relacionados

• Transformation by the v-fms oncogene product: role of glycosylational processing and cell surface expression.
• Tyrosine phosphorylations in vivo associated with v-fms transformation.
• Evidence that a second tumor antigen coded by adenovirus early gene region E1a is required for efficient cell transformation.
• Deletions in the C-terminal coding region of the v-sis gene: dimerization is required for transformation.
• Polyoma viral middle T-antigen is required for transformation.